• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON SARL GYNECARE TVT SECUR SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON SARL GYNECARE TVT SECUR SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC Back to Search Results
Catalog Number TVTS4
Device Problems Migration or Expulsion of Device (1395); Appropriate Term/Code Not Available (3191)
Patient Problems Erosion (1750); Incontinence (1928); Unspecified Infection (1930); Pain (1994); Abnormal Vaginal Discharge (2123); Urinary Frequency (2275); Blood Loss (2597); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).To date, the device has not been returned.If the product is returned for evaluation, any further info derived from the evaluation will be submitted in a supplemental 3500a form.
 
Event Description
It was reported by an attorney that the patient underwent a gynecological surgical procedure on (b)(6) 2008 and unknown mesh was implanted.It was reported that she experienced undisclosed injuries.No additional information was provided.
 
Manufacturer Narrative
(b)(4).It was reported that the patient underwent a gynecological surgical procedure on (b)(6) 2008 and tvt-secur was implanted.It was reported that she experienced pain, erosion of her internal bodily tissue and other injuries following the procedure.It was reported that the patient has undergone multiple surgeries and revisionary procedures.No additional information was provided.In addition, a device history review has been inserted into the file.  this review indicates that there was no quality concerns associated with the manufacturing process.
 
Manufacturer Narrative
(b)(4).It was reported that following insertion, the patient experienced vaginal discharges, bacterial vaginosis, urinary incontinence and frequency.
 
Manufacturer Narrative
(b)(4).Additional narrative: it was reported that following insertion the patient experienced infection, urinary and bowel problems, fistulae, recurrence, bleeding, neuromuscular problems, and vaginal scarring.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GYNECARE TVT SECUR SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC
Manufacturer (Section D)
ETHICON SARL
puits-godet 20
neuchatel NJ 2000
SZ  2000
Manufacturer (Section G)
ETHICON SARL-NEUCHATEL
puits-godet 20
neuchatel NJ 2000
SZ   2000
Manufacturer Contact
krystina laguna
route 22 westp o box 151
somerville, NJ 08876
9082183043
MDR Report Key5758197
MDR Text Key48432943
Report Number2210968-2016-10063
Device Sequence Number1
Product Code PAH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K052401
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 05/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2009
Device Catalogue NumberTVTS4
Device Lot Number3101773
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/20/2016
Initial Date FDA Received06/29/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Not provided
Supplement Dates FDA Received12/08/2016
01/19/2017
01/27/2017
05/17/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/28/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age37 YR
-
-